Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion type Assertion NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_head.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_provenance.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion evidence source_evidence_literature NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_provenance.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion SIO_000772 17606710 NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_provenance.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion wasDerivedFrom befree-2016 NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_provenance.
- NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_assertion wasGeneratedBy ECO_0000203 NP618146.RAPoPEpglpkms71SWO0T1OpWmgnehLMnCCV-H98yHrwSo130_provenance.